Table of Contents >> Show >> Hide
The first quarter of 2025 looked, at first glance, like a cold shower for insurance M&A. Deal count dropped, headlines got moodier, and the usual chorus of “this is the year activity returns” suddenly sounded like it needed a second cup of coffee. In the insurance agency and brokerage world, announced transactions slid to a five-year first-quarter low, reinforcing the sense that buyers had become more selective and sellers more cautious. But here’s the twist: this was not a market in retreat so much as a market in transition.
That distinction matters. A true retreat looks like fear, silence, and everyone hiding behind spreadsheets. What happened instead was more interesting. Smaller deals slowed, yes, but strategic logic did not disappear. It got pickier. Buyers still want scale, specialty capabilities, deeper middle-market access, stronger employee benefits platforms, and better data-driven distribution. Private equity still has capital to put to work. Public brokers still need growth. And large privately owned agencies still have reasons to test the market while valuations remain attractive.
So the better headline is not simply that M&A fell. It is that the market spent the first quarter sorting out who was serious, who was priced for a different era, and who could still justify writing very large checks. The result was a slower start in deal volume, but with every sign that major transactions were still lining up backstage, waiting for their cue.
Why the First Quarter Felt So Quiet
Lower deal count, higher selectivity
In insurance distribution, the first-quarter slowdown was real. Announced agency and brokerage transactions came in below the pace of the same period a year earlier, and well below what the market got used to during the post-pandemic consolidation boom. That drop reflected a mix of caution and discipline. Buyers did not vanish; they simply became fussier. They were less interested in doing deals for the sake of doing deals and more focused on margin, fit, geography, specialty niches, integration risk, and long-term revenue quality.
Think of it like dating, but for corporate balance sheets. Everybody still wants a relationship. They just stopped pretending every profile looked like “the one.”
Macro uncertainty kept the brakes lightly pressed
The broader deal environment did not help. Across the M&A market, 2025 opened with a strange mix of optimism and hesitation. Large-deal sentiment improved, yet uncertainty around inflation, tariffs, regulation, financing costs, and economic growth made boards a little slower to sprint into the chapel. In plain English: executives liked the idea of acquisitions, but many preferred not to buy the company equivalent of a fixer-upper at luxury-home prices.
That mood was especially visible in insurance, where acquirers care deeply about recurring revenue, retention, producer economics, and the hidden mess that may live inside an acquired platform. When conditions feel less predictable, due diligence gets longer, valuation debates get louder, and timelines get elastic. Nothing kills first-quarter momentum faster than a room full of advisors saying, “Let’s revisit this after one more quarter of data.”
Why Big Deals Still Loom
The industry is still fragmented
Even after years of consolidation, insurance distribution remains highly fragmented. That means the strategic logic behind M&A is still powerful. Large brokers want more middle-market share. Specialty platforms want deeper expertise in areas such as management liability, cyber, construction, employee benefits, and wholesale distribution. Private equity-backed firms want scale so they can improve leverage, sharpen operating efficiency, and eventually recapitalize or exit at a higher multiple.
In other words, the reasons to do deals did not disappear. If anything, they became more urgent. Scale is not just about bragging rights anymore. It is about negotiating power, technology investment, producer recruiting, carrier relationships, and the ability to cross-sell more intelligently across a broader client base.
Private equity has not left the building
One of the clearest signals that the market still has fuel is private equity’s continued influence. PE-backed and hybrid buyers remained the dominant force in insurance transactions, which means capital is still there, platforms are still active, and sponsors still need paths to growth and liquidity. Broader M&A research tells the same story: dry powder remains significant, and many investment firms entered 2025 expecting to deploy capital more aggressively.
That matters because private equity rarely enjoys letting capital age gracefully. Money on the sidelines does not earn its halo by sitting still. It wants acquisitions, recapitalizations, and strategic combinations that can create a bigger story for the next buyer.
The Deals Everyone Is Watching
If first-quarter volume looked sleepy, the marquee transactions told a very different story. The insurance brokerage market has not lost its appetite for transformative combinations; it has simply concentrated that appetite into fewer, more consequential deals.
Gallagher and Woodruff Sawyer
Arthur J. Gallagher’s $1.2 billion acquisition of Woodruff Sawyer was a textbook example of what buyers still want: respected specialty capabilities, strong middle- and large-market relationships, and a platform that instantly strengthens important lines such as management liability, construction, real estate, and cyber. Woodruff Sawyer was not a random bolt-on. It was a meaningful strategic fit with scale, brand recognition, and attractive expertise.
Gallagher and AssuredPartners
Then there is the much larger pending Gallagher deal for AssuredPartners, valued at $13.45 billion. That transaction underscores the broader point of the quarter: while small and midsize deal flow may wobble, truly strategic buyers are still willing to swing hard for middle-market leadership, expanded distribution, and long-term revenue growth. It is difficult to call the M&A market “dead” with a straight face when deals of this size are still under active review.
Brown & Brown and Accession Risk Management
Brown & Brown’s agreement to buy Accession Risk Management for roughly $9.83 billion added more proof that the biggest players are not waiting politely on the sidelines. This was not just another acquisition; it was a reshaping move. Accession brings Risk Strategies and One80 Intermediaries into Brown & Brown’s orbit, along with sizable premium volume, meaningful revenue, and deeper specialty distribution reach. When deals like that get signed, the market message is unmistakable: large-scale consolidation still has legs.
The earlier benchmark deals still cast a long shadow
The backdrop to all of this includes Aon’s $13 billion acquisition of NFP and Marsh McLennan’s $7.75 billion purchase of McGriff Insurance Services. Those deals helped reset expectations around what strategic buyers are willing to pay for scale, talent, and middle-market capabilities. They also made it easier for quality sellers to believe that waiting for the right buyer could still be worth the patience.
What the Slow Quarter Really Means for Agencies and Brokers
For sellers: quality still commands attention
A lower headline deal count does not mean good agencies suddenly became unwanted. It means buyers are scrutinizing quality more intensely. Firms with strong organic growth, durable retention, niche expertise, healthy producer economics, and clean financial reporting can still draw serious interest. In fact, a selective market can benefit top-tier sellers because buyers have fewer distractions and more reason to focus on standout assets.
That said, “quality” now has sharper edges. Buyers want less mystery and more proof. They want clear carrier concentration data, transparent EBITDA bridges, realistic producer transition plans, and evidence that growth is not being propped up by one rainmaker who may vanish after closing.
For buyers: scale is only valuable if it integrates well
Buyers remain active, but they are no longer impressed by volume alone. The market is rewarding thoughtful expansion, especially where a target strengthens a specialty line, adds geographic density, or deepens middle-market capabilities. The trick is integration. If the acquired firm cannot be folded into a stronger platform without cultural chaos, client disruption, or producer defection, the math can get ugly fast.
This is why many acquisitive firms now look less like serial collectors and more like curators. They are not just buying revenue. They are buying the future shape of their operating model.
For the industry: this may be a pause, not a peak
The first-quarter low looks more like a reset than a collapse. Multiple indicators suggest that large-deal momentum still has support: active buyers remain in market, private equity capital still needs deployment, financing alternatives are available, and the strategic case for consolidation remains intact. Broader M&A research has also pointed to a rebound led from the top of the market, where larger transactions carry the value story even when smaller deals lag.
That is why the current moment feels less like the end of the cycle and more like a sorting process. The market is deciding which deals deserve to happen, not whether deals deserve to happen at all.
What Could Delay the Rebound
Still, optimism should wear sensible shoes. Several risks could slow the expected pickup. Interest-rate uncertainty can still pressure financing and valuations. Regulatory review can stretch timelines on larger combinations. Tariff-related economic noise can unsettle boardrooms. And the valuation gap between what some sellers want and what disciplined buyers will actually pay has not fully disappeared.
There is also the integration question hanging over the biggest transactions. Large combinations may create impressive headlines, but they also absorb management attention. If the major consolidators spend more time digesting what they already bought, some middle-market deal flow could take longer to accelerate.
Even so, the market’s center of gravity still points toward continued consolidation. The players may be moving more carefully, but they are not moving backward.
Experience From the Market: What This Trend Feels Like in Real Life
Spend time talking with agency owners, bankers, private equity sponsors, and serial acquirers, and a pattern becomes obvious. Nobody is acting as though M&A has lost relevance. They are acting as though mistakes got more expensive. That is an important difference.
For many sellers, the experience of 2025 has been less about panic and more about recalibration. Owners who expected a crowded auction in 30 days have discovered that the market now rewards preparation over speed. Firms with polished financials, credible organic growth, stable leadership benches, and a clear specialty story still generate strong interest. Firms that rely on vague optimism, messy reporting, or “trust us, it’ll all make sense in diligence” are finding fewer buyers willing to play detective.
Buyers, meanwhile, are operating with a sharper pencil. The era of grabbing almost anything with recurring commissions and a nice office sign has faded. Acquirers are asking tougher questions about retention, cross-sell potential, producer contracts, carrier relationships, technology readiness, and whether a target genuinely fills a strategic gap. They are also spending more time thinking about post-close execution. In past years, the deal itself often felt like the trophy. Now the trophy is the integration plan that actually works.
Private equity-backed platforms are living this reality in a particularly intense way. They still need growth, and they still need eventual exits, but they also know that the next buyer will scrutinize platform quality just as hard as they once scrutinized their own targets. That has made many firms more deliberate. Rather than chase sheer quantity, they are looking for acquisitions that improve the eventual exit narrative: more specialty depth, more benefits expertise, more wholesale capability, better geographic density, stronger leadership teams, and more resilient margins.
Public brokers are dealing with their own version of the same pressure. Investors like growth, but they like disciplined growth better. That helps explain why the biggest public players have not abandoned M&A; they have become more intentional about where they place their giant bets. A transformative acquisition can still make perfect sense when it accelerates scale, expands middle-market relevance, or brings in a specialty engine that would take years to build organically.
From the outside, all of this can make the market look contradictory. Deal count softens, yet confidence in big strategic moves survives. Small deals slow, yet mega-deals keep surfacing. The contradiction is only apparent. What the market is really saying is simple: average assets may have a harder time finding a buyer at yesterday’s expectations, but exceptional assets and strategically important platforms still command attention. In practice, that means 2025 is shaping up to be less of a volume race and more of a quality contest. And in insurance M&A, quality has a funny way of attracting very large checks.
Conclusion
M&A in insurance did hit a five-year first-quarter low in 2025, and that deserves attention. But the bigger story is not weakness alone. It is the widening gap between ordinary deal flow and extraordinary deal logic. Smaller transactions slowed because buyers became more selective and macro conditions remained noisy. Yet the underlying drivers of consolidationfragmentation, scale needs, specialty expansion, private equity pressure, and middle-market competitionremain firmly in place.
So yes, the first quarter looked sluggish. But sluggish is not the same as stalled. In fact, the biggest announced and pending transactions suggest the market may simply be saving its loudest moves for later. If the first quarter was a whisper, the rest of the year may still bring a very expensive megaphone.
Close